From a course to a population
What does the average per person or episode mean?
First, we assign a duration and average intensity to an included experience. Multiplying its days by 24 and its average intensity, then dividing by 47.25, gives USU for that modeled course. It is a working assumption about the whole course, including relief, sleep and milder periods.
For a single-course report, every included person or episode receives that same allowance. When a report uses ordinary and fatal illness courses, we calculate the two groups separately. The average shown in the list is their combined USU divided by the combined count. It is weighted by the number of cases in each group, rather than taking a simple average of the two course values.
The denominator matters. Outbreak entries show USU per reported case, displacement entries show USU per person in the selected cohort, and the treated-malnutrition entry shows USU per admission. Case and admission counts do not necessarily identify unique individuals. These are cumulative course averages, not daily rates or population-wide averages.
Source coverage, reporting periods, case mix and omitted experiences still differ. A larger modeled average does not establish that every individual experienced greater suffering, and it does not measure the value of a life. See a worked example →
8 shared course templates
Why these durations and intensities?
Sources support symptom descriptions and, where available, typical duration windows. The exact numerical intensity is our judgment in every template.
Dengue: other reported cases
5 days · average intensity 3 / 10
The existing five-day acute course is retained for cases not reported dead at the snapshot cutoff. WHO gives a 2-7-day symptom window. Five days is a representative choice, not a measured mean or a survivor-specific estimate. Other cases include unresolved outcomes and severe cases not reported dead; no future deaths are imputed. Later fatigue is excluded. [S2]
Fever, headache, body/joint aches and nausea support a meaningful acute symptom burden. Assigned intensity 3 is a working average across the whole day, including relief and sleep. It is lower than a severe-pain peak. WHO does not establish the value 3 or its ratio to the reference. [S2]
Excluded: Later fatigue, prolonged recovery, a separate severity adjustment for other reported cases, caregiver distress, bereavement, unreported infections, death itself and lost life years.
Flood displacement: initial distress
30 days · average intensity 2 / 10
We assign the same 30-day initial course to each person in the selected flood-displaced cohort. Reports of continuing displacement and difficult living conditions support a multiweek scenario. None measures a 30-day cohort mean. This is a consistency choice, not evidence of equal recovery time or a month actually spent in a shelter. [S6] [S10] [S11] [S12]
WHO describes anxiety, sadness, sleep problems and other distress after emergencies. Assigned intensity 2 represents a modest whole-day average across the selected cohort, including relief and people with little distress. This provisional mapping to the pain reference is especially weak; WHO supplies no numeric conversion. [S7]
Excluded: Injury and disease episodes, suffering before death, bereavement, later mental-health effects, distress outside the selected cohort and post-death loss.
Chikungunya: other reported cases
8 days · average intensity 4 / 10
CDC describes acute symptoms typically resolving within 7-10 days. We retain eight days for cases outside the selected CHIKV-attributable fatal group. This is a representative choice, not an observed outbreak mean or proof of survival; unresolved outcomes and other-cause deaths are not reclassified. Persistent joint symptoms are excluded from this ordinary course. [S4]
CDC describes potentially severe, debilitating joint symptoms; Paraguay's adult suspected-case definition included incapacitating joint pain or arthritis. These support testing a higher average than dengue. Assigned intensity 4, and the 4:3 ratio, remain model judgments rather than measured equivalence. [S3] [S4]
Excluded: Persistent or recurrent joint pain beyond the assigned course, extra severity profiles for other cases, caregiver distress, bereavement, unreported infections, death itself, lost life years and suffering after death.
Bundibugyo Ebola: other reported cases
14 days · average intensity 5 / 10
The original all-case assumption of 14 days is retained for cases not reported dead at the cutoff. Historical series reported courses around 9-10 days in Uganda and 15-18 days in Isiro. Fourteen days is a rounded choice, not a pooled mean, a survivor-specific estimate or an observed 2026 average. Unresolved cases remain in this group; no future deaths are imputed. [S14] [S15]
The studies describe headache, muscle and abdominal pain, gastrointestinal symptoms and marked weakness. We assign intensity 5 as a provisional combined whole-day average, allowing for treatment, relief and sleep. Neither study measured USU intensity. Choosing 5 rather than the dengue value 3 or chikungunya value 4 is a model judgment, not a demonstrated clinical ratio. [S14] [S15]
Excluded: Incubation without symptoms, persistent post-Ebola symptoms, caregiver distress, bereavement, unconfirmed or unreported illness, and post-death loss. Individual severity and time to death or recovery are not reconstructed.
Bundibugyo Ebola: fatal illness
12 days · average intensity 6 / 10
We select 12 days between the historical median onset-to-death durations of 9 days in Uganda and 15 days in Isiro. It represents the complete symptomatic course ending at death, not an extra terminal period. It is not a pooled mean or an observed 2026 average; the studies were small and treatment settings differed. [S14] [S15]
We assign intensity 6 as a combined time-average of pain and other acute distress over the whole fatal course, including relief, sleep and intervals without experience. This is a provisional judgment above the existing value 5, not a measured USU mapping. Concurrent symptoms are represented together and are not added again. No intensity is assigned after death or to known absence of experience. [S14] [S15]
Excluded: Incubation without symptoms, caregiver distress, bereavement, death itself, lost life years and suffering after death. Individual trajectories and conscious time are not measured.
Dengue: fatal illness
7 days · average intensity 5 / 10
Seven days is a provisional representative course from symptom onset to death. A Puerto Rico series of 58 fatal laboratory-positive cases reported a median of 7.1 days; in a Malaysian review of 322 deaths, 66.5% occurred on illness days 4-7. A Singapore series of 28 adults reported a longer median of 12 days. These differing populations support testing alternatives. Seven days is our choice, not a pooled mean or an observed average for the listed outbreaks. [S18] [S19] [S20]
We assign intensity 5 as one combined average for pain and other experienced distress throughout the fatal illness. Clinical descriptions of abdominal pain, vomiting and breathing difficulty motivate testing a higher average than the ordinary value 3. The exact value 5 and its ratio to 3 are judgments, not measured USU conversions. This elapsed-time average allows for earlier milder illness, treatment, relief, sleep and periods without experience; it is not a constant severe-pain score. [S17]
Excluded: Incubation without symptoms, death itself, lost life years, caregiver distress, bereavement and suffering after death. Individual symptom and consciousness trajectories are not measured; no extra terminal period is added.
Chikungunya: attributable fatal illness
28 days · average intensity 5 / 10
A Ceará, Brazil series reported a mean onset-to-death interval of 28 days and a median of 15 days across 245 laboratory-confirmed deaths. We borrow the mean for this simple aggregate model. It includes later deaths and is not a measured Paraguay average. Differences in ages, care and death attribution limit transferability. The course represents the complete symptomatic illness ending at death, not an extra terminal period. [S21]
We assign intensity 5 as a combined elapsed-time average, above the ordinary value 4. A Paraguay adult ICU study describes fever, gastrointestinal symptoms and neurological involvement, but does not measure USU intensity or a complete onset-to-death course. The exact value and 5:4 ratio are judgments, allowing for relief, sleep and intervals without experience. This is not a constant conscious pain score. No suffering is assigned after death. [S22]
Excluded: Death itself, lost life years, caregiver distress, bereavement and suffering after death. No separate joint-pain or terminal-period allowance is added. Age-specific courses, symptom-free intervals and consciousness histories are not reconstructed.
Treated severe acute malnutrition: early illness and recovery
42 days · average intensity 2 / 10
We assign a six-week course after admission. Historical outpatient programmes in South Sudan, a different country, reported 2021 mean stays of 42.3, 43.2 and 46.3 days under three adapted protocols. These provide context for a multiweek window. Forty-two days is our rounded choice, not measured suffering duration in Sudan in 2026. Nutritional treatment can continue after clinical improvement; pre-admission suffering is excluded. [S26] [S27]
Malnutrition can involve physical discomfort, digestive problems and irritability, while children eligible for outpatient care may have good appetite and no acute problems requiring hospital care. We assign 2 as a combined average across people and elapsed time, including improvement, relief, sleep and intervals without experience. The value is below the ordinary dengue value 3 because this course averages over a longer recovery window. Both the value and this comparison are judgments, not validated ratios to kidney-stone pain. Concurrent symptoms are bundled once. [S27] [S28]
Excluded: Suffering before treatment admission, untreated children, moderate malnutrition, later or recurrent episodes outside the selected courses, long-term developmental harm, separate infection or injury burdens, broader conflict and displacement distress, caregiver distress, bereavement, death itself, lost life years and suffering after death.
Testing the assumptions
Show the inputs that matter
Every crisis report tests duration and intensity for every included course. Source counts, mortality eligibility and the reference unit stay fixed. The central scenarios reproduce the existing headlines.
The combined lower and higher scenarios change both duration and intensity for all included courses. The separate input table changes one assumption at a time, making it easier to see what drives the total. These choices are illustrative and have no assigned probabilities. They are not confidence intervals, minimum or maximum burden, or a complete uncertainty analysis.
The ordinary dengue alternatives use 2 to 7 days and intensity 2 to 4, with the central course still 5 days at intensity 3. Two days replaces the previous three-day shorter scenario and follows the short end of the symptom window cited in S2. Clinical duration evidence does not establish a numerical intensity. Fatal-course combinations use the duration and intensity alternatives already documented for each course; other profiles retain their previous endpoints.
Case underreporting, source disagreements, omitted experiences and the validity of the common scale are separate uncertainties. Where a source supplies a conflicting count, the report retains its own count comparison. A small change in the fatal component cannot establish that the whole estimate is precise.
See the Brazil dengue example · All combined scenarios (CSV) · Reproduce the scenarios (Python)